Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts

P. Ferdinándy, Yori Appelbaum, C. Csonka, Ingolf E. Blasig, A. Tósaki

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

1. The role of nitric oxide (NO) was studied in the control of ischaemic/reperfused cardiac function and the effect of N,N,N',N'-tetrakis-[2-pyridylmethyl]l-ethylenediamine (TPEN), a potent metal chelator, on the regulation of cardiac NO formation. 2. Rat isolated working hearts were subjected to 30 min ischaemia and reperfusion. The incidence of reperfusion-induced ventricular fibrillation (VF), ventricular tachycardia (VT) and the recovery of cardiac function were measured. Nitric oxide was detected by electron spin resonance (ESR) spectroscopy. 3. With 5.0, 7.5 and 10.0 μmol/L of TPEN administered prior to ischaemia, the drug produced a reduction in the incidence of VF from its control value of 100% to 25% (P <0.05), 17% (P <0.05) and 8% (P <0.05), respectively. The incidence of VT followed the same pattern. 4. When TPEN was given at the moment of reperfusion, a reduction in the incidence of VF and VT was still observed. Reduction in the incidence of VF and VT was reflected in the improvement of cardiac function both in the pre- and postischaemic TPEN-treated groups. 5. TPEN reduced basal cardiac NO content and prevented the accumulation of NO during ischaemia/reperfusion. 6. The results show that TPEN exerts beneficial effects on postischaemic cardiac function and dysrhythmias in relation to inhibition of the accumulation of NO in ischaemic/reperfused myocardium.

Original languageEnglish
Pages (from-to)496-502
Number of pages7
JournalClinical and Experimental Pharmacology and Physiology
Volume25
Issue number7-8
Publication statusPublished - 1998

Fingerprint

Chelating Agents
Nitric Oxide
Metals
Ventricular Fibrillation
Ventricular Tachycardia
Reperfusion
Incidence
Ischemia
Recovery of Function
Electron Spin Resonance Spectroscopy
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine
Cardiac Arrhythmias
Myocardium
Pharmaceutical Preparations

Keywords

  • Cardiac function
  • Dysrhythmias
  • Ischaemia/reperfusion
  • Isolation heart
  • Nitric oxide
  • Rat
  • TPEN

ASJC Scopus subject areas

  • Physiology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts. / Ferdinándy, P.; Appelbaum, Yori; Csonka, C.; Blasig, Ingolf E.; Tósaki, A.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 25, No. 7-8, 1998, p. 496-502.

Research output: Contribution to journalArticle

@article{d112d1f1d65048ae988e9ce0bce7067c,
title = "Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts",
abstract = "1. The role of nitric oxide (NO) was studied in the control of ischaemic/reperfused cardiac function and the effect of N,N,N',N'-tetrakis-[2-pyridylmethyl]l-ethylenediamine (TPEN), a potent metal chelator, on the regulation of cardiac NO formation. 2. Rat isolated working hearts were subjected to 30 min ischaemia and reperfusion. The incidence of reperfusion-induced ventricular fibrillation (VF), ventricular tachycardia (VT) and the recovery of cardiac function were measured. Nitric oxide was detected by electron spin resonance (ESR) spectroscopy. 3. With 5.0, 7.5 and 10.0 μmol/L of TPEN administered prior to ischaemia, the drug produced a reduction in the incidence of VF from its control value of 100{\%} to 25{\%} (P <0.05), 17{\%} (P <0.05) and 8{\%} (P <0.05), respectively. The incidence of VT followed the same pattern. 4. When TPEN was given at the moment of reperfusion, a reduction in the incidence of VF and VT was still observed. Reduction in the incidence of VF and VT was reflected in the improvement of cardiac function both in the pre- and postischaemic TPEN-treated groups. 5. TPEN reduced basal cardiac NO content and prevented the accumulation of NO during ischaemia/reperfusion. 6. The results show that TPEN exerts beneficial effects on postischaemic cardiac function and dysrhythmias in relation to inhibition of the accumulation of NO in ischaemic/reperfused myocardium.",
keywords = "Cardiac function, Dysrhythmias, Ischaemia/reperfusion, Isolation heart, Nitric oxide, Rat, TPEN",
author = "P. Ferdin{\'a}ndy and Yori Appelbaum and C. Csonka and Blasig, {Ingolf E.} and A. T{\'o}saki",
year = "1998",
language = "English",
volume = "25",
pages = "496--502",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "7-8",

}

TY - JOUR

T1 - Role of nitric oxide and TPEN, a potent metal chelator, in ischaemic and reperfused rat isolated hearts

AU - Ferdinándy, P.

AU - Appelbaum, Yori

AU - Csonka, C.

AU - Blasig, Ingolf E.

AU - Tósaki, A.

PY - 1998

Y1 - 1998

N2 - 1. The role of nitric oxide (NO) was studied in the control of ischaemic/reperfused cardiac function and the effect of N,N,N',N'-tetrakis-[2-pyridylmethyl]l-ethylenediamine (TPEN), a potent metal chelator, on the regulation of cardiac NO formation. 2. Rat isolated working hearts were subjected to 30 min ischaemia and reperfusion. The incidence of reperfusion-induced ventricular fibrillation (VF), ventricular tachycardia (VT) and the recovery of cardiac function were measured. Nitric oxide was detected by electron spin resonance (ESR) spectroscopy. 3. With 5.0, 7.5 and 10.0 μmol/L of TPEN administered prior to ischaemia, the drug produced a reduction in the incidence of VF from its control value of 100% to 25% (P <0.05), 17% (P <0.05) and 8% (P <0.05), respectively. The incidence of VT followed the same pattern. 4. When TPEN was given at the moment of reperfusion, a reduction in the incidence of VF and VT was still observed. Reduction in the incidence of VF and VT was reflected in the improvement of cardiac function both in the pre- and postischaemic TPEN-treated groups. 5. TPEN reduced basal cardiac NO content and prevented the accumulation of NO during ischaemia/reperfusion. 6. The results show that TPEN exerts beneficial effects on postischaemic cardiac function and dysrhythmias in relation to inhibition of the accumulation of NO in ischaemic/reperfused myocardium.

AB - 1. The role of nitric oxide (NO) was studied in the control of ischaemic/reperfused cardiac function and the effect of N,N,N',N'-tetrakis-[2-pyridylmethyl]l-ethylenediamine (TPEN), a potent metal chelator, on the regulation of cardiac NO formation. 2. Rat isolated working hearts were subjected to 30 min ischaemia and reperfusion. The incidence of reperfusion-induced ventricular fibrillation (VF), ventricular tachycardia (VT) and the recovery of cardiac function were measured. Nitric oxide was detected by electron spin resonance (ESR) spectroscopy. 3. With 5.0, 7.5 and 10.0 μmol/L of TPEN administered prior to ischaemia, the drug produced a reduction in the incidence of VF from its control value of 100% to 25% (P <0.05), 17% (P <0.05) and 8% (P <0.05), respectively. The incidence of VT followed the same pattern. 4. When TPEN was given at the moment of reperfusion, a reduction in the incidence of VF and VT was still observed. Reduction in the incidence of VF and VT was reflected in the improvement of cardiac function both in the pre- and postischaemic TPEN-treated groups. 5. TPEN reduced basal cardiac NO content and prevented the accumulation of NO during ischaemia/reperfusion. 6. The results show that TPEN exerts beneficial effects on postischaemic cardiac function and dysrhythmias in relation to inhibition of the accumulation of NO in ischaemic/reperfused myocardium.

KW - Cardiac function

KW - Dysrhythmias

KW - Ischaemia/reperfusion

KW - Isolation heart

KW - Nitric oxide

KW - Rat

KW - TPEN

UR - http://www.scopus.com/inward/record.url?scp=0031875560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031875560&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 496

EP - 502

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - 7-8

ER -